Relief Therapeutics Holding AG (RLFTF)

[rollup]

You got that wrong with the 2nd link- this INHALED study ends 12/31/21and 2 more sites were added.


Unique Protocol ID: RLF-100_002
Brief Title: Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19 (AVICOVID-2)
Official Title: Inhaled ZYESAMI™ for the Treatment of Severe COVID-19
Secondary IDs:
Open or close this module Study Status
Record Verification: October 2021 November 2021
Overall Status: Recruiting
Study Start: February 15, 2021
Primary Completion: December 15, 2021 [Anticipated]
[color=red]Study Completion: December 31, 2021 [Anticipated][/color]

The study IV (Remdesivir/Placebo) will now be finished already in the 1st Q to read out ( more safety!!!)data.....